Does a continuous-flow left ventricular assist device improve survival free from stroke and device failure in patients with advanced heart failure compared to a pulsatile device?
patients with advanced heart failure
continuous-flow left ventricular assist device
pulsatile device
survival free from stroke and device failure at 2 yearscomposite
Continuous-flow LVADs provide superior 2-year survival free from stroke and device failure compared to pulsatile devices in patients with advanced heart failure.
Treatment with a continuous-flow left ventricular assist device in patients with advanced heart failure significantly improved the probability of survival free from stroke and device failure at 2 years as compared with a pulsatile device. Both devices significantly improved the quality of life and functional capacity. (ClinicalTrials.gov number, NCT00121485.)
Building similarity graph...
Analyzing shared references across papers
Loading...
Mark S. Slaughter
University of Louisville
Joseph G. Rogers
Heart Failure & Transplant
Carmelo A. Milano
Cardiac Surgery
New England Journal of Medicine
The Ohio State University
Duke Medical Center
Johns Hopkins Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...
Slaughter et al. (Tue,) studied this question.
synapsesocial.com/papers/69e0c8353dcc343e9cc12048 — DOI: https://doi.org/10.1056/nejmoa0909938